³Õ±ð°ù²õ²¹³¾±ð²ú
Versameb is a Basel-based biotechnology company focusing on discovering and developing RNA-based drugs for modulation of protein expression.
4
Funding Rounds
$24.1m
Money raised
Overview
Versameb is a Basel-based biotechnology company focusing on discovering and developing RNA-based drugs for modulation of protein expression.
-
Website:
- Business model: B2B
- Headquarters: Basel
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company ³Õ±ð°ù²õ²¹³¾±ð²ú has raised a total of $24.1m in funding over 4 rounds.
Key Insights:
- Versameb Seed round, July 2020: $6m
- Versameb July 2020 Seed Funding Round: $6.4m
- Versameb Seed C round, October 2019: $6.4m
- Versameb Seed round, December 2018: $5.3m
Versameb Seed round, July 2020
$6m
Versameb July 2020 Seed Funding Round
$6.4m
Versameb Seed C round, October 2019
$6.4m
Versameb Seed round, December 2018
$5.3m
Industries
³Õ±ð°ù²õ²¹³¾±ð²ú is active in the following industries: